VistaGen Therapeutics, Inc.
VTGN
$0.70
$0.0913.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.27M | -18.90M | -19.42M | -15.10M | -13.64M |
| Total Depreciation and Amortization | 190.00K | 189.00K | 185.00K | 169.00K | 166.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 757.00K | 953.00K | 950.00K | 794.00K | 835.00K |
| Change in Net Operating Assets | -873.00K | 126.00K | 4.52M | -4.71M | 2.57M |
| Cash from Operations | -16.20M | -17.63M | -13.76M | -18.85M | -10.06M |
| Capital Expenditure | 0.00 | -26.00K | -60.00K | -65.00K | -88.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.00K | 130.00K | -34.00K | -723.00K | 615.00K |
| Cash from Investing | -99.00K | 104.00K | -94.00K | -788.00K | 527.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 1.02M | -- |
| Total Debt Repaid | -283.00K | -278.00K | -274.00K | -90.00K | -- |
| Issuance of Common Stock | 0.00 | 2.39M | 27.93M | 558.00K | 1.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -283.00K | 2.11M | 27.65M | 1.49M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.58M | -15.42M | 13.80M | -18.15M | -7.58M |